Apex Trader Funding - News
RaySearch Laboratories: Interim report April - June 2024
STOCKHOLM, Aug. 16, 2024 /PRNewswire/ --
SECOND QUARTER (APRIL- JUNE 2024)
Order intake SEK 290.3 M (239.2)
Net sales SEK 318.9 M (239.5)
Operating profit SEK 79.3 M (18.2)
Profit after tax SEK 61.4 M (10.9)
Earnings per share before/after dilution SEK 1.79 (0.32)
Cash flow from operating activities SEK 154.6 M (67.2)
Order backlog SEK 1,790.5 M (1,954.9) at the end of the period
HALF-YEAR (JANUARY- JUNE 2024)
Order intake SEK 528.8 M (445.8)
Net sales SEK 576.1 M (469.6)
Operating profit SEK 125.1 M (41.9)
Profit after tax SEK 98.1 M (28.5)
Earnings per share before/after dilution SEK 2.86 (0.83)
Cash flow from operating activities SEK 321.9 M (220.9)
SIGNIFICANT EVENTS DURING THE SECOND QUARTER